(S)-2-(2'-(6-(2-(4-fluorobenzylamino)-2-oxo-1-phenylethylcarbamoyl)quinolin-2-ylcarbamoyl)biphenyl-4-yl)-2-methylpropanoic acid

ID: ALA2147295

Chembl Id: CHEMBL2147295

PubChem CID: 71456411

Max Phase: Preclinical

Molecular Formula: C42H35FN4O5

Molecular Weight: 694.76

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C(=O)O)c1ccc(-c2ccccc2C(=O)Nc2ccc3cc(C(=O)N[C@H](C(=O)NCc4ccc(F)cc4)c4ccccc4)ccc3n2)cc1

Standard InChI:  InChI=1S/C42H35FN4O5/c1-42(2,41(51)52)31-18-14-27(15-19-31)33-10-6-7-11-34(33)39(49)46-36-23-17-29-24-30(16-22-35(29)45-36)38(48)47-37(28-8-4-3-5-9-28)40(50)44-25-26-12-20-32(43)21-13-26/h3-24,37H,25H2,1-2H3,(H,44,50)(H,47,48)(H,51,52)(H,45,46,49)/t37-/m0/s1

Standard InChI Key:  XVWYLDUPXZROGU-QNGWXLTQSA-N

Associated Targets(Human)

MTTP Tclin Microsomal triglyceride transfer protein large subunit (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 694.76Molecular Weight (Monoisotopic): 694.2591AlogP: 7.44#Rotatable Bonds: 11
Polar Surface Area: 137.49Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.18CX Basic pKa: 1.68CX LogP: 7.97CX LogD: 4.93
Aromatic Rings: 6Heavy Atoms: 52QED Weighted: 0.11Np Likeness Score: -1.16

References

1. Robinson RP, Bartlett JA, Bertinato P, Bessire AJ, Cosgrove J, Foley PM, Manion TB, Minich ML, Ramos B, Reese MR, Schmahai TJ, Swick AG, Tess DA, Vaz A, Wolford A..  (2011)  Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.,  21  (14): [PMID:21684740] [10.1016/j.bmcl.2011.05.099]

Source